Uttam Saha
18Patents
3h-index
25Co-inventors
60Inventor score
Filing activity: Jun 13, 2003 → Sep 13, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7101865B2 | 24-sulfoximine vitamin D3 compounds | Human Necessities | 38 | Expired |
| US7973024B2 | 24-sulfoximine vitamin D3 compounds | Human Necessities | 17 | Active |
| US7710155B2 | Dynamic dual output latch | Electricity | 12 | Active |
| US8106035B2 | 25-SO2-substituted analogs of 1μ,25-dihydroxyvitamin D3 | Chemistry; Metallurgy | 1 | Expired |
| US11322200B1 | Single-rail memory circuit with row-specific voltage supply lines and boost circuits | Physics | 1 | Active |
| US11795148B2 | Compounds and methods for inhibiting CYP26 enzymes | Human Necessities | 0 | Active |
| US11050414B1 | Dynamic single input-dual output latch | Electricity | 0 | Active |
| US8906888B2 | Low-calcemic 16,23-diene 25-oxime analogs of 1α,25-dihydroxy vitamin D3 | Human Necessities | 0 | Active |
| US12388427B2 | Retention flip-flop with multiple positive supply voltage domains | Electricity | 0 | Active |
| US9775903B2 | 1-deoxy analogs of 1,25-dihydroxyvitamin D3 compounds | Chemistry; Metallurgy | 0 | Active |
| US11358933B2 | Compounds and methods for inhibiting CYP26 enzymes | Human Necessities | 0 | Active |
| US11453798B2 | Formaldehyde free binder and multi-component nanoparticle | Performing Operations; Transporting | 0 | Active |
| US8039676B2 | Process for producing phosphine oxide vitamin D precursors | Emerging Cross-Sectional Technologies | 0 | Active |
| US9198923B2 | Phosphate management with small molecules | Human Necessities | 0 | Active |
| US11495288B2 | Low-leakage sense circuit, memory circuit incorporating the low-leakage sense circuit, and method | Physics | 0 | Active |
| US11218137B2 | Low clock load dynamic dual output latch circuit | Electricity | 0 | Active |
| US11926583B2 | Stabilized 1, 25-dihydroxyvitamin D2 and method of making same | Human Necessities | 0 | Active |
| US12297173B2 | Compounds and methods for inhibiting CYP26 enzymes | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.